Hillary Clinton has weighed in on the mounting controversy over rising drug prices charged by an area drug manufacturing, calling for Mylan Pharmaceuticals to “immediately reduce” rising prices for the EpiPen.

Prices for the EpiPen, which delivers a potentially life-saving dose of epinephrine to those with severe allergies, have risen ten-fold since the Canonsburg generic drug maker acquired the product. They’ve risen from $60 in 2007 to roughly $600 now.

In her statement, Ms. Clinton called the increases “outrageous." While she praised pharmaceutical companies for "giving us revolutionary treatments,” she added, "[I]t's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."

As the Post-Gazette reported this morning, a bipartisan group of U.S. Senators has raised their own objections, seeking a price reduction and a closer look into Mylan's practices.

Advertise with us

Mylan did not return the Post-Gazette's calls for comment yesterday, but on its website the company says "Ensuring access to epinephrine ... is a core part of our mission." It touted efforts to provide EpiPen injectors in schools, and a "savings card" that it said enabled 80 percent of commercially-insured patients to obtain EpiPens with no out-of-pocket costs. The firm acknowledged that an increasing number of households had high-deductible health plans with higher drug costs, but added it was "committed to working [on] solutions to meet the needs of the patients and families we serve."

Ms. Clinton's statement touted her own plan to reduce drug costs, which includes the withdrawal of federal research subsidies for drug companies earning excess profits (as determined by a panel of industry experts). The statement added that "pharmaceutical manufacturers should be required to explain significant price increases, and prove that any additional costs are linked to additional patient benefits and better value. Since there is no apparent justification in this case, I am calling on Mylan to immediately reduce the price of EpiPens. "

Complicating the politics here, as many in the national press have been discovering today, is the fact that Mylan's CEO, Heather Bresch, is the daughter of West Virginia Senator Joe Manchin, a Democrat. Mr. Manchin endorsed Ms. Clinton a year ago.